Totally agree. So many factors go into a bio succeeding and luck is a big one. Executing on the business plan even a couple of years later than planned can mean so much more dilution, which crimps shareholder returns in a big way.
- Forums
- Commodities
- Biotech Analysts $4M pa
Biotech Analysts $4M pa, page-17
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online